Search

Your search keyword '"Aulakh, Sonikpreet"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Aulakh, Sonikpreet" Remove constraint Author: "Aulakh, Sonikpreet"
137 results on '"Aulakh, Sonikpreet"'

Search Results

5. Autologous Cell Immunotherapy (IGV-001) with IGF-1R Antisense Oligonucleotide in Newly Diagnosed Glioblastoma Patients

7. VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma.

9. Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

11. Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients.

12. RTID-08. A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY WITH ANTISENSE OLIGO IMV-001 TARGETING IGF-1R, VS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS

13. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target

17. The Roadmap to Pituitary in COVID-19 Crisis

19. PATH-22. CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA

23. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.

25. Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomas (HGGs).

27. Abstract PO-104: Disparity in race and age reporting in landmark cancer clinical trials: Underrepresentation of the traditionally underserved U.S. population

29. Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

31. Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases

36. Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses

38. Contributors

40. Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia

45. Disparity in Clinical Trial Opportunities for Patients with B-Cell Malignancies in the United States

46. Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome

47. Timeliness of Initial Therapy in Multiple Myeloma (MM): Trends and Factors Influencing Patient Care

48. Trends in the Risk of Second Primary Malignancies (SPMs) Among Survivors of Chronic Lymphocytic Leukemia(CLL)

50. EXTH-06. CD38-TARGETED THERAPY IN GLIOBLASTOMA

Catalog

Books, media, physical & digital resources